HDFC Pharma and Healthcare Fund Growth Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

HDFC Pharma and Healthcare Fund Growth Fund Overview

Min. investment

SIP ₹100 & Lump. ₹100

AUM (Fund size)

₹3,311 Cr

Lock In Period

N/A

Expense Ratio

2.16

Exit Load

In respect of each purchase/switch-in of units, an Exit load of 1% is payable if units are redeemed /switched-out within 30 days from the date of allotment.No Exit Load is payable if units are redeemed / switchedout after 30 days from the date of allotment.

Benchmark

BSE Healthcare

HDFC Pharma and Healthcare Fund Growth Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M-2.05-1.09-0.20
6M25.293.9529.54
1Y25.193.9328.78
3Y0.0014.0385.33

Portfolio Analysis

  • Equity: 98.42%
  • Debt: 1.58%
  • Others
As on: 2026-08-31
View allocation % by

1. Divis Laboratories Ltd.9.54%
2. Sun Pharmaceutical Industries Ltd.8.94%
3. Torrent Pharmaceuticals Ltd.4.08%
4. Lupin Ltd.4.04%
5. Cipla Ltd.3.94%
6. Neuland Laboratories Limited3.70%
7. Anthem Biosciences Limited3.48%
8. Acutaas Chemicals Limited3.24%
9. Ipca Laboratories Ltd.3.23%
10. Shilpa Medicare Ltd3.10%
11. Alkem Laboratories Ltd.3.06%
12. Rubicon Research Limited2.82%
13. Glenmark Pharmaceuticals Ltd.2.34%
14. Zydus Lifesciences Limited1.93%
15. Dr Reddys Laboratories Ltd.1.90%
16. Biocon Ltd.1.73%
17. Wockhardt Ltd.1.61%
18. Sai Life Sciences Limited1.60%
19. SYMBIOTEC PHARMALAB LIMITED1.21%
20. Ajanta Pharma Limited1.18%
21. Gland Pharma Ltd.1.09%
22. CORONA REMEDIES LIMITED1.07%
23. Eris Lifesciences Ltd1.06%
24. Jubilant Pharmova Limited0.85%
25. BAJAJ HEALTHCARE LIMITED0.57%
26. Novartis India Ltd.0.47%
27. Cohance Lifesciences Limited0.34%

1. Max Healthcare Institute Limited4.06%
2. Aster DM Quality Care Limited3.84%
3. Global Health Limited2.85%
4. Fortis Healthcare Limited2.37%
5. Krishna Institute Of Medical Sciences Limited2.25%
6. Vijaya Diagnostic Centre Limited2.24%
7. Jupiter Life Line Hospitals Limited1.94%
8. Metropolis Healthcare Ltd.1.90%
9. Molbio Diagnostics Limited1.77%
10. Apollo Hospitals Enterprise Ltd.1.39%
11. Thyrocare Technologies Ltd.1.31%
No Data Found
No Data Found

About Fund HDFC Pharma and Healthcare Fund Growth

HDFC Pharma and Healthcare Fund Growth managed by HDFC Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹3,311 Crore. The fund benchmarks its performance against the BSE Healthcare while maintaining an expense ratio of 2.16. Under the expert guidance of Nikhil Mathur ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

Nikhil Mathur

Mr. Nikhil Mathur holds PGDM - IMT, Ghaziabad, B.E. (Civil) - PEC, Chandigarh, CFA (USA) level 3 cleared. He has over 7 years of experience in equity research and 2 years in financial advisory.

Peer Comparison

Fund NameRatingsAUMExpense Ratio
Kotak Healthcare Fund Growth0767 CR2.6
PGIM India Healthcare Fund Growth0125 CR2.58
HDFC Pharma and Healthcare Fund Growth03,310 CR2.16
UTI Healthcare Fund Growth31,443 CR2.2
SBI Healthcare Opportunities Fund Growth35,796 CR2
Fund Name1Y3Y
This FundKotak Healthcare Fund Growth26.75410
This FundPGIM India Healthcare Fund Growth23.51720
This FundHDFC Pharma and Healthcare Fund Growth25.18740
This FundUTI Healthcare Fund Growth15.549878.7274
This FundSBI Healthcare Opportunities Fund Growth19.001679.6672

HDFC Pharma and Healthcare Fund Growth FAQs

HDFC Pharma and Healthcare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of HDFC Pharma and Healthcare Fund Growth is 2.16. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

HDFC Pharma and Healthcare Fund Growth’s fund performance is as follows:
  • 1 Month : -2.05%
  • 6 Months : 25.29%
  • 1 Year : 25.19%
  • 3 Years : 0.00%
Returns of HDFC Pharma and Healthcare Fund Growth are updated daily based on NAV of ₹ 21.213 as on Oct 01,2026. Since inception, the return has been 0.00%.

You can invest in HDFC Pharma and Healthcare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of HDFC Pharma and Healthcare Fund Growth is ₹3,311 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in HDFC Pharma and Healthcare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.
  • Daily Research Calls
  • ₹0 AMC for First Year
  • Dedicated RM Support
Open a Free Demat Account
+ Free 1st Year AMC